Clorgyline, formerly known as Clorgiline, M&B 9302 or MB9302, is a potent, irreversible and selective inhibitor of monoamine oxidase (MAO), it is structurally related to pargyline which is described as an antidepressant. Specifically, it is an irreversible (covalent) and selective inhibitor of monoamine oxidase A (MAO-A). Clorgiline was never marketed, but it has found use in scientific research. In addition to its actions as an MAOI, clorgiline has been found to bind with high affinity to the σ1 receptor (Ki = 3.2 nM) and with very high affinity to the I2 imidazoline receptor (an allosteric site on the monoamine oxidase enzyme) (Ki = 40 pM).
Physicochemical Properties
| Molecular Formula | C13H16CL3NO |
| Molecular Weight | 272.1703 |
| Exact Mass | 307.029 |
| CAS # | 17780-75-5 |
| Related CAS # | 17780-72-2;17780-75-5 (HCl); |
| PubChem CID | 4380 |
| Appearance | White to off-white solid powder |
| Boiling Point | 361.3ºC at 760mmHg |
| Flash Point | 172.3ºC |
| Vapour Pressure | 2.1E-05mmHg at 25°C |
| LogP | 4.129 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 6 |
| Heavy Atom Count | 17 |
| Complexity | 263 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | BTFHLQRNAMSNLC-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C13H15Cl2NO/c1-3-7-16(2)8-4-9-17-13-6-5-11(14)10-12(13)15/h1,5-6,10H,4,7-9H2,2H3 |
| Chemical Name | N-(3-(2,4-dichlorophenoxy)propyl)-N-methylprop-2-yn-1-amine hydrochloride |
| Synonyms | M&B 9302 MB 9302 MB-9302 MB9302Clorgyline HCl Clorgyline hydrochloride Clorgiline |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline). Journal of neural transmission. Supplementum 52: 39-48. [2]. Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats. Eur J Neurosci. 2006 Dec;24(12):3532-40. [3]. Conjugated dopamine in superfusates of slices of rat striatum. J Neurochem. 1982 Nov;39(5):1333-9. |
| Additional Infomation |
Clorgyline is an aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant. It has a role as an EC 1.4.3.4 (monoamine oxidase) inhibitor and an antidepressant. It is a tertiary amino compound, a terminal acetylenic compound, an aromatic ether and a dichlorobenzene. An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE. An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE. |
Solubility Data
| Solubility (In Vitro) |
DMSO : ≥ 100 mg/mL (~324.01 mM) H2O : ~100 mg/mL (~324.01 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (8.10 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (8.10 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (8.10 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.6742 mL | 18.3709 mL | 36.7417 mL | |
| 5 mM | 0.7348 mL | 3.6742 mL | 7.3483 mL | |
| 10 mM | 0.3674 mL | 1.8371 mL | 3.6742 mL |